Dechert

Intellectual Property

Partner

John P. Rearick, Ph.D. is a partner in Dechert's intellectual property group, leveraging his knowledge of pharmaceutical and chemical technologies to tailor strategic IP protection that aligns with clients’ immediate and long-term business objectives. His practice also entails conducting comprehensive due diligence assessments for acquirers and investors.

With over a decade of experience, Dr. Rearick has successfully obtained more than 200 U.S. patents for his clients. He has considerable experience in securing global patent coverage for innovative small molecule treatments, particularly in the spheres of oncology, infectious disease, and neurodegenerative disorders. His work with pharmaceutical clients encompasses strategies to extend exclusivity for their drug product portfolios. Additionally, he counsels clients on contentious patent matters before the Patent Trial and Appeal Board (PTAB) and navigating post-grant challenges related to product-critical patents in Europe and other international jurisdictions.

Dr. Rearick was also the recipient of a Howard Hughes Medical Institute Predoctoral Fellowship in Biological Sciences and a Certificate of Distinction in Teaching from Harvard College.

Purdue University, B.S., 2001 Harvard University, A.M., 2004 Harvard University, Ph.D., Chemistry, 2007 Boston University School of Law, J.D., 2013